XenoPort News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

21.06.16	Arbor Pharmaceuticals, LLC -- Moody's Assigns B1 CFR to Arbor Pharmaceuticals; Stable Outlook (Moodys)
24.05.16	EXEL Rises On Trial Data, XNPT Agrees To Be Acquired, NVO Faces FDA Panel Today (RTTNews)
23.05.16	XenoPort Agrees To Be Acquired By Arbor Pharma In $467 Mln Deal - Quick Facts (RTTNews)
28.03.16	Dr. Reddy's Granted U.S. Rights For XenoPort's Clinical-stage XP23829 (RTTNews)
16.09.15	KOOL Tweaks Workforce, VNDA To Face FDA, XNPT Crashed For A Reason, TRIV Zooms (RTTNews)
20.02.15	Mark Your Calendar For TCON, XLRN, Xenon Lights Up, MACK Gets Going (RTTNews)
05.11.14	News & Moves: CDXS, CVV, IOSP, XNPT (RTTNews)
24.06.14	ASPX Awaits Results, BZYR Creating Buzz, CGIX Opens Wallet, GNCA Hits A High (RTTNews)
15.05.14	Reckitt Benckiser Pharma, XenoPort Sign License Agreement - Quick Facts (RTTNews)
24.01.14	XenoPort Prices Upsized Underwritten Public Offering At $6.00 Per Share (RTTNews)
21.01.14	XenoPort Plans To Sell 10 Mln Shares In Underwritten Public Offering (RTTNews)
12.01.14	XenoPort Provides Update On XP23829 Development & HORIZANT Business (RTTNews)
15.10.13	Clinton Group Calls on Xenoport to Hire a New CEO and Focus on Promising Drug in its Pipeline (PR Newswire)
19.11.09	Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome (Businesswire)
03.11.09	XenoPort Reports Third Quarter Financial Results (Businesswire)
19.10.09	XenoPort Announces Initiation of a Phase 2b Clinical Trial of Arbaclofen Placarbil in Patients with Gastroesophageal Reflux Disease (Businesswire)
08.09.09	XenoPort Reports Preliminary Results From a Safety and Tolerability Trial of Arbaclofen Placarbil in Patients With Acute Back Spasms (Businesswire)
05.05.09	XenoPort Reports First Quarter Financial Results (Businesswire)
05.03.09	XenoPort to Present at the Cowen Healthcare Conference (Businesswire)
02.12.08	XenoPort Reports Results from a Phase 2 Clinical Trial of XP19986 as a Treatment for the Symptoms of Gastroesophageal Reflux Disease (Businesswire)
14.02.08	XenoPort Reports Fourth Quarter and Year-End 2007 Financial Results (Businesswire)
03.01.08	XenoPort Announces Initiation of Clinical Trials (Businesswire)
10.09.07	XenoPort Announces Results of a Phase 1 Clinical Trial and Plans for Additional Phase 2 Clinical Trials of XP19986 (Businesswire)
14.02.07	XenoPort Reports Fourth Quarter and Year-End 2006 Financial Results (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu XenoPort Inc.

Aktien Top/Flop

Meistgelesene Nachrichten